000 01269 a2200385 4500
005 20250512053839.0
264 0 _c19861113
008 198611s 0 0 eng d
022 _a0300-8916
024 7 _a10.1177/030089168607200408
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBattista, R
245 0 0 _aPreliminary observations on intravenous idarubicin (4-demethoxydaunorubicin) in the chronic and accelerated phase of chronic myelogenous leukemia.
_h[electronic resource]
260 _bTumori
_cAug 1986
300 _a389-93 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAntibiotics, Antineoplastic
_xadministration & dosage
650 0 4 _aDaunorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIdarubicin
650 0 4 _aLeukemia, Myeloid
_xblood
650 0 4 _aLeukocyte Count
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPlatelet Count
700 1 _aD'Emilio, A
700 1 _aVespignani, M
700 1 _aPacciarini, M A
700 1 _aDini, E
773 0 _tTumori
_gvol. 72
_gno. 4
_gp. 389-93
856 4 0 _uhttps://doi.org/10.1177/030089168607200408
_zAvailable from publisher's website
999 _c3469854
_d3469854